CHJTF
Price
$1.05
Change
-$0.10 (-8.70%)
Updated
Jun 18 closing price
Capitalization
9.91B
CMOPF
Price
$64.37
Change
+$9.37 (+17.04%)
Updated
May 28 closing price
Capitalization
827.91M
Interact to see
Advertisement

CHJTF vs CMOPF

Header iconCHJTF vs CMOPF Comparison
Open Charts CHJTF vs CMOPFBanner chart's image
CSPC Pharmaceuticals Group
Price$1.05
Change-$0.10 (-8.70%)
Volume$19.71K
Capitalization9.91B
Cosmo Pharmaceuticals
Price$64.37
Change+$9.37 (+17.04%)
Volume$200
Capitalization827.91M
CHJTF vs CMOPF Comparison Chart in %
Loading...
CHJTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMOPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CHJTF vs. CMOPF commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHJTF is a Hold and CMOPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (CHJTF: $1.05 vs. CMOPF: $64.37)
Brand notoriety: CHJTF and CMOPF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CHJTF: 97% vs. CMOPF: 100%
Market capitalization -- CHJTF: $9.91B vs. CMOPF: $827.91M
CHJTF [@Pharmaceuticals: Major] is valued at $9.91B. CMOPF’s [@Pharmaceuticals: Major] market capitalization is $827.91M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHJTF’s FA Score shows that 2 FA rating(s) are green whileCMOPF’s FA Score has 1 green FA rating(s).

  • CHJTF’s FA Score: 2 green, 3 red.
  • CMOPF’s FA Score: 1 green, 4 red.
According to our system of comparison, CHJTF is a better buy in the long-term than CMOPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHJTF’s TA Score shows that 3 TA indicator(s) are bullish while CMOPF’s TA Score has 3 bullish TA indicator(s).

  • CHJTF’s TA Score: 3 bullish, 2 bearish.
  • CMOPF’s TA Score: 3 bullish, 1 bearish.
According to our system of comparison, CMOPF is a better buy in the short-term than CHJTF.

Price Growth

CHJTF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while CMOPF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.13%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Reported Earning Dates

CHJTF is expected to report earnings on May 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.13% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHJTF($9.91B) has a higher market cap than CMOPF($828M). CMOPF has higher P/E ratio than CHJTF: CMOPF (68.49) vs CHJTF (11.52). CHJTF YTD gains are higher at: 77.485 vs. CMOPF (-3.818). CHJTF has higher annual earnings (EBITDA): 7.63B vs. CMOPF (42.1M). CHJTF has more cash in the bank: 13.4B vs. CMOPF (222M). CMOPF has less debt than CHJTF: CMOPF (176M) vs CHJTF (683M). CHJTF has higher revenues than CMOPF: CHJTF (31.1B) vs CMOPF (104M).
CHJTFCMOPFCHJTF / CMOPF
Capitalization9.91B828M1,197%
EBITDA7.63B42.1M18,114%
Gain YTD77.485-3.818-2,029%
P/E Ratio11.5268.4917%
Revenue31.1B104M29,904%
Total Cash13.4B222M6,036%
Total Debt683M176M388%
FUNDAMENTALS RATINGS
CHJTF vs CMOPF: Fundamental Ratings
CHJTF
CMOPF
OUTLOOK RATING
1..100
9448
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4354
PRICE GROWTH RATING
1..100
3661
P/E GROWTH RATING
1..100
1597
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMOPF's Valuation (15) in the null industry is in the same range as CHJTF (23). This means that CMOPF’s stock grew similarly to CHJTF’s over the last 12 months.

CMOPF's Profit vs Risk Rating (100) in the null industry is in the same range as CHJTF (100). This means that CMOPF’s stock grew similarly to CHJTF’s over the last 12 months.

CHJTF's SMR Rating (43) in the null industry is in the same range as CMOPF (54). This means that CHJTF’s stock grew similarly to CMOPF’s over the last 12 months.

CHJTF's Price Growth Rating (36) in the null industry is in the same range as CMOPF (61). This means that CHJTF’s stock grew similarly to CMOPF’s over the last 12 months.

CHJTF's P/E Growth Rating (15) in the null industry is significantly better than the same rating for CMOPF (97). This means that CHJTF’s stock grew significantly faster than CMOPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHJTFCMOPF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
30%
Bullish Trend 1 day ago
20%
Momentum
ODDS (%)
Bullish Trend 1 day ago
28%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
40%
Bearish Trend 1 day ago
6%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
33%
Bullish Trend 1 day ago
23%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
35%
Bullish Trend 1 day ago
23%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
50%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
35%
Bullish Trend 1 day ago
23%
View a ticker or compare two or three
Interact to see
Advertisement
CHJTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMOPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRAGX104.76N/A
N/A
Bridgeway Aggressive Investors 1
NWJFX111.65N/A
N/A
Nationwide NYSE Arca Tech 100 Idx InsSvc
AISHX6.00N/A
N/A
Aristotle Small/Mid Cap Equity C
OTCFX56.94N/A
N/A
T. Rowe Price Small-Cap Stock
LADVX28.99N/A
N/A
Lord Abbett Developing Growth R6

CHJTF and

Correlation & Price change

A.I.dvisor tells us that CHJTF and CSPCY have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHJTF and CSPCY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHJTF
1D Price
Change %
CHJTF100%
N/A
CSPCY - CHJTF
23%
Poorly correlated
+4.50%
DSKYF - CHJTF
7%
Poorly correlated
-2.39%
CHGCF - CHJTF
1%
Poorly correlated
-9.99%
CMOPF - CHJTF
-0%
Poorly correlated
N/A
DSNKY - CHJTF
-0%
Poorly correlated
-2.41%
More

CMOPF and

Correlation & Price change

A.I.dvisor tells us that CMOPF and GSK have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CMOPF and GSK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMOPF
1D Price
Change %
CMOPF100%
N/A
GSK - CMOPF
22%
Poorly correlated
-0.86%
NVS - CMOPF
21%
Poorly correlated
-1.54%
CHGCY - CMOPF
7%
Poorly correlated
-0.89%
DSNKY - CMOPF
5%
Poorly correlated
-2.41%
CSPCY - CMOPF
4%
Poorly correlated
+4.50%
More